Patents/Inventors

David Scott Johnson

San Francisco, CAUS11 patents

11 Patents

US125903862026
Recombinant Polyclonal Proteins and Methods of Use Thereof
Gigagen, Inc.
0 cites
US124977112025
Engineered Cells Expressing Anti-viral T Cell Receptors and Methods of Use Thereof
Gigamune, Inc.
0 cites
US124213112025
Anti-ctla-4 Binding Proteins and Methods of Use Thereof
Gigagen, Inc.
0 cites
US124046072025
Recombinant Polyclonal Proteins Targeting COVID-19 and Methods of Use Thereof
Gigagen, Inc.
0 cites
US123716892025
Engineered Enveloped Vectors and Methods of Use Thereof
Gigamune, Inc.
0 cites
US122411782025
Recombinant Fusion Proteins and Libraries from Immune Cell Repertoires
Gigagen, Inc.
0 cites
US121958802025
Systems and Methods for Massively Parallel Combinatorial Analysis of Single Cells
Gigagen, Inc.
0 cites
US117186602023
Recombinant Polyclonal Proteins Targeting Zika and Methods of Use Thereof
Gigagen, Inc.
0 cites
US117027652023
Recombinant Fusion Proteins and Libraries from Immune Cell Repertoires
Gigagen, Inc.
0 cites
US116857792023
Recombinant Polyclonal Proteins Targeting COVID-19 and Methods of Use Thereof
Gigagen, Inc.
0 cites
US115916522023
System and Methods for Massively Parallel Analysis of Nucleic Acids in Single Cells
Gigagen, Inc.
0 cites